Start your company with ACE!
Do you dream of starting your own company but don’t know where to begin? Join the ACE Incubation Program. We help founders build their startup with 12 weeks of training and support by leading mentors and business coaches. Sign up for our upcoming program (starts April 1st). Once you are accepted into the program, you will benefit from our extensive network of startup coaches, mentors, corporate innovators and investors.
> We kick off the Incubation Program with a one-week full-time Bootcamp, lead by SILICON VALLEY expert Gigi Wang!
The Incubation Program is meant to help MSc students & researchers from the institutes set up a successful company. ACE provides the resources to build and grow your startup. Based within Amsterdam Science Park’s startup community at Startup Village, ACE’s workshops take place within the heart of innovation! ACE is the university incubator of UvA, VU, HvA and Amsterdam UMC.
ACE’s startup portfolio consists of over 150 tech and science-based startups. Check out our startup page to get a feel for some of the industries our startups work in, from AI and Big Data to chemistry and advanced instrumentation. In 2017, AI startup Scyfer was acquired by IT giant Qualcomm. Other successful companies include Metrica Sports – a football data tracking company, LUMICKS – the leading supplier of single molecular analysis, and many more!
Did you know? In 2018, ACE was named #1 Incubator in the Netherlands in the Emerce100!
Click to read more.
CWI researcher Peter Boncz has been appointed as one of the 2022 fellows of the Association of Computing Machinery (ACM).
The ADS Thesis Award winners for 2022 are Philipp Sommerhalter and Sarah Kwakkelaar in the BSc category and Krijn Doekemeijer and Julia Sudnik for the MSc category. The winners were announced at the ADS Highlights Event on the 8th of December 2022!
A symposium entitled ‘From Systems and Networks to Complex Cyber Infrastructures’ took place on 9th December 2022 in honor of Cees de Laat (UvA IvI) and Leon Gommans (UvA IvI).